NZAC News and Press, SPDR MSCI ACWI Climate Paris Aligned ETF From 05/17/22

Stock markets have seen immense volatility this year. The sharply rising inflation, Russia’s invasion of Ukraine and central banks raising interest rates are all weighing on equities. With volatility expected to remain high, reducing equity risk can be challenging but achie...

The rising rate, rising dollar environment continues with the dollar index hitting a 20-year high last week. That rising dollar is having an impact on the rest of the global economy but so far it has been manageable. There are a lot of companies out there that have come public over th...

Our macroeconomic forecasting team assesses how the war and latest survey data have altered the economic outlook, policymaking and recession risks. Global growth was dragged lower, principally by steep contractions in Russia and mainland China. Barring the initial COVID-19 outbreak, M...

Movements in global sector indices are consistent with investors reappraising portfolio allocations and shifting objectives towards capital preservation in real terms. The volatility in interest rate expectations has flowed into FX markets. We maintain a neutral outlook on global ...

We're seeing declining asset prices from bond to equities, and in some cases, real assets because of higher inflation. We are seeing early signs that inflation is starting to moderate. Equity market is currently pricing in the probability of a mild recession. For further det...

While growth outside of China has shown some encouraging resilience, losing only marginal momentum in April on average, this can be linked to resurgent spending on consumer services amid loosened COVID-19 restrictions. Worsening supply chain delays meanwhile contributed to renewed out...

The pace of global economic growth slowed in April to the lowest since the downturn of the second quarter of 2020. While an easing of COVID-19 containment measures on average globally helped to sustain service sector growth in April, the rate of expansion in the service sector fell to...

Bausch Health has seen a very tough 2022 as investors price in higher interest rates on its massive debt load and softer IPO of its subsidiary Bausch + Lomb. These are not encouraging trends, but the valuation reset has been enormous, potentially creating an opportunistic investment o...